16.02.2013. Pharmaco Economics: The Economic Burden of Depression in Switzerland
24-04-2013

Share

Despite the high prevalence of depression,
information about the burden of this disease in Switzerland
is scarce. A better knowledge of the costs of depression
may provide important information for future national
preventive programmes, optimizing cost-effective budget-
ing. The estimates of national costs may improve the
public’s awareness of depression and depression-related
costs, breaking down the taboo of depression as an illness.

Um den ganzen Artikel in englisch zu lesen, einfach den unteren Link anklicken.

Download PDF

Back to Archive

Leave a Reply

Your email address will not be published.